WAT Medical Enterprise Ltd.
WAT Medical develops precise, wearable and smart medical products to prevent debilitating conditions like nausea, migraine and obesity. Current medical solutions often involve drug intake, which can cause further discomfort through various side-effects.
WAT Medical develops technologies that use non-invasive neuronal electrical stimulation, including transcutaneous electrical nerve stimulation (TENS) and transcranial direct current stimulation (tDCS), which involve electrical currents conducted from the skin.
WAT Medical consists of leaders in the field of medical research and product development who are devoted to provide effective and convenient therapy options to users around the world.
- TENS technology
- Wearable
- Targeted nerve stimulation
- Innovation
Our Commitment to Reduce Waste
In addition to providing high-quality medical devices, WAT Medical strives to make the production process as eco-friendly as possible. All products are packaged using recycled cardboard, with the goal of completely removing all plastics in packages by 2022.
Global Intellectual Property Rights
WAT Medical’s brands and products have global intellectual property rights, including patents, trademarks, qualification certificates, and production quality systems.
CE
EmeTerm and HeadaTerm are approved by the European Union for Class II medical devices.
FDA
EmeTerm and HeadaTerm are approved by the US FDA for Class II medical devices.
Health Canada
EmeTerm and HeadaTerm are approved by the Health for Class II medical devices.
TGA
EmeTerm and HeadaTerm are authorized for medical device registration through AU distributors
Awards and achievements
- WAT Medical is certified to the ISO 13485 medical standard.
- WAT Medical is a member of LifeSciences BC.
- EmeTerm and HeadaTerm bear the CE Medical mark.
- Its anti-nausea wristband, EmeTerm, is winner of iF Design Award 2017.
- Its anti-obesity wristband, ObeEnd, is winner of iF Design Award 2021 and Reddot Winner 2021.
Scientific research and technical capabilities
WAT Medical has two R&D teams in Canada and the United States, each of which includes top technical R&D personnel, clinicians, and senior product development members in the field. Our team aims to innovate and develop various types of home wearable medical products.
In order to keep the research and development technology in the field of neuroelectric stimulation at the forefront of the world, WAT Medical has invested heavily in setting up a technology research and development laboratory with advanced standards in Canada, and continues to invest funds to explore and experiment with cutting-edge technologies.